Efficacy and safety of fecal microbiota transplant in irritable bowel syndrome: An update based on meta‐analysis of randomized control trials
Authors:
Open Access
- 12 September 2022
- journal article
- research article
- Published by Wiley in Health Science Reports
- Vol. 5 (5) , e814
Abstract
Background and Aims: Fecal microbiota transfer (FMT) is a potential treatment for irritable bowel syndrome (IBS). Several randomized trials have tested FMT effects using different routes of administration, doses, and sample sizes. We aim to assess the overall efficacy of FMT for IBS patients and the safety of the intervention.Methods: We systematically searched four databases for randomized control trials that studied the efficacy and safety of FMT in IBS patients.Results: We included 8 randomized trials (472 patients) that compared FMT with placebo in IBS patients. Pooled results showed no statistically significant difference between FMT and control groups in the overall change in IBS symptom severity (IBS‐SSS) at 1 month (p = 0.94), 3/4 months (p = 0.82), and at the end of trials (p = 0.67). No significant difference in the total number of respondents between the FMT and control groups (risk ratios = 1.84, [95% confidence interval (CI) = 0.82–2.65], p = 0.19). Although the oral route of administration showed a significant difference in the number of respondents (p = 0.004), there was no statistically significant difference in the IBS‐SSS when subgrouping the oral route of administration (mean difference = 47.57, [95% CI = −8.74–103.87], p = 0.10).Conclusion: FMT is not an effective treatment to relieve all the symptoms of IBS. Even in the groups that showed relatively significant improvement after FMT, the effect was proven to wear off over time and the re‐administration carries a low success rate. Future research should consider different bacterial‐based interventions such as probiotics or specific antibiotics.Keywords
This publication has 47 references indexed in Scilit:
- Atomic structures of a bactericidal contractile nanotube in its pre- and postcontraction statesNature Structural & Molecular Biology, 2015
- Irritable Bowel SyndromeJAMA, 2015
- Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysisWorld Journal of Gastroenterology, 2015
- Antibiotic Treatment of Constipation-Predominant Irritable Bowel SyndromeDigestive Diseases and Sciences, 2014
- A Controlled Trial of Gluten-Free Diet in Patients With Irritable Bowel Syndrome-Diarrhea: Effects on Bowel Frequency and Intestinal FunctionGastroenterology, 2013
- Fermentable Carbohydrate Restriction Reduces Luminal Bifidobacteria and Gastrointestinal Symptoms in Patients with Irritable Bowel SyndromeThe Journal of Nutrition, 2012
- Intestinal microbiota in functional bowel disorders: a Rome foundation reportGut, 2012
- The brain–gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based studyGut, 2012
- Original Research:Bacillus coagulansSignificantly Improved Abdominal Pain and Bloating in Patients with IBSPostgraduate Medicine, 2009
- Targeted Killing of Streptococcus mutans by a Pheromone-Guided “Smart” Antimicrobial PeptideAntimicrobial Agents and Chemotherapy, 2006